CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Conditions
Advanced Biliary Tract Carcinoma · Advanced Colorectal Carcinoma · Advanced Gastroesophageal Junction Adenocarcinoma · Advanced Lung Adenocarcinoma · Advanced Malignant Solid Neoplasm · Advanced Ovarian Carcinoma · Advanced Pancreatic Carcinoma · Advanced Urothelial Carcinoma · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 · Metastatic Biliary Tract Carcinoma · Metastatic Colorectal Carcinoma · Metastatic Gastroesophageal Junction Adenocarcinoma · Metastatic Lung Adenocarcinoma · Metastatic Ovarian Carcinoma · Metastatic Pancreatic Carcinoma · Metastatic Urothelial Carcinoma · Refractory Biliary Tract Carcinoma · Refractory Colorectal Carcinoma · Refractory Gastroesophageal Junction Adenocarcinoma · Refractory Lung Adenocarcinoma · Refractory Ovarian Carcinoma · Refractory Pancreatic Carcinoma · Refractory Urothelial Carcinoma · Stage II Pancreatic Cancer AJCC v8 · Stage III Colorectal Cancer AJCC v8 · Stage III Lung Cancer AJCC v8 · Stage III Ovarian Cancer AJCC v8 · Stage III Pancreatic Cancer AJCC v8 · Stage IV Colorectal Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8 · Stage IV Ovarian Cancer AJCC v8 · Stage IV Pancreatic Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Northwestern University, Chicago, Illinois, United States
Contact: Principal Investigator (Devalingam Mahalingam, MD, PhD)
Study leads
Devalingam Mahalingam
Principal Investigator
Northwestern University